In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (282)
Video
Strategies to Encourage the Adoption of Biosimilars
November 04, 2022
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Article
High Specialty Drug Costs: A Challenge in Need of Powerful Protection
November 02, 2022
Plan sponsors are overlooking simple strategies to increase specialty medication adherence.
Article
Addressing Health Inequities
October 31, 2022
All too often, a person’s gender, race, education, income or zip code dictates how healthy they are.
Video
What are biosimilars?
October 17, 2022
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Article
The Future of Prior Authorization
October 12, 2022
The advancements that will accelerate the delivery of proper treatment, reduce administrative burden, and improve the overall care experience for patients and providers.
Article
A Worsening Depression Crisis in Teens
October 07, 2022
COVID-19 and other recent events have likely exacerbated stress and depression among teenagers in the United States, who already struggle with mental health stigmas and access to medications and therapies.
